CCS
CADX

Crosspoint Capital Strategies’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Crosspoint Capital Strategies’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-782
Closed -$11K – 691
2013
Q4 		$11K Buy
+782
New +$11K ﹤0.01% 426